Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Peter Maxwell

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Seminars in Dialysis|May 20, 2003
Skin thickness and subcutaneous erythropoietinA Peter Maxwell
Kidney International|July 12, 2002
Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failureA Peter Maxwell
The Practitioner|April 23, 2008
Blood pressure control key in polycystic kidney diseaseJoanne Shields, A Peter Maxwell
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2008
Heme oxygenase 1: does it have a role in renal cytoprotection?Aisling E Courtney, A Peter Maxwell
The Practitioner|April 26, 2007
Renal stone recurrence can be preventedAisling E Courtney, A Peter Maxwell
Human Mutation|December 17, 2008
Annotated chromosome maps for renal diseaseAmy Jayne McKnight, Donal O'Donoghue, A Peter Maxwell
Stem Cells (Dayton, Ohio)|November 29, 2002
EPO's alter ego: erythropoietin has multiple actionsTerence R Lappin, A Peter Maxwell, Patrick G Johnston
European Journal of Heart Failure|April 18, 2002
Influence of progressive renal dysfunction in chronic heart failureA Peter Maxwell, Hean Y Ong, D Paul Nicholls
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2006
Identifying genes for diabetic nephropathy--current difficulties and future directionsBryan R Conway, David A Savage, A Peter Maxwell
Nephron. Clinical Practice|August 1, 2007
Cost should be the principal determinant of choice of erythropoiesis-stimulating agent in chronic haemodialysis patientsAisling E Courtney, Peter T McNamee, A Peter Maxwell
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Seminars in Dialysis|May 20, 2003
Skin thickness and subcutaneous erythropoietinA Peter Maxwell
Kidney International|July 12, 2002
Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failureA Peter Maxwell
The Practitioner|April 23, 2008
Blood pressure control key in polycystic kidney diseaseJoanne Shields, A Peter Maxwell
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2008
Heme oxygenase 1: does it have a role in renal cytoprotection?Aisling E Courtney, A Peter Maxwell
The Practitioner|April 26, 2007
Renal stone recurrence can be preventedAisling E Courtney, A Peter Maxwell
Human Mutation|December 17, 2008
Annotated chromosome maps for renal diseaseAmy Jayne McKnight, Donal O'Donoghue, A Peter Maxwell
Stem Cells (Dayton, Ohio)|November 29, 2002
EPO's alter ego: erythropoietin has multiple actionsTerence R Lappin, A Peter Maxwell, Patrick G Johnston
European Journal of Heart Failure|April 18, 2002
Influence of progressive renal dysfunction in chronic heart failureA Peter Maxwell, Hean Y Ong, D Paul Nicholls
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2006
Identifying genes for diabetic nephropathy--current difficulties and future directionsBryan R Conway, David A Savage, A Peter Maxwell
Nephron. Clinical Practice|August 1, 2007
Cost should be the principal determinant of choice of erythropoiesis-stimulating agent in chronic haemodialysis patientsAisling E Courtney, Peter T McNamee, A Peter Maxwell
Pageof 4